Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Lamont announces new CT business assistance

Connecticut Governor Ned Lamont has announced that the first proposals he is submitting to the Connecticut General Assembly during the 2020 legislative session will be a...

| By Kelley Gipson

JAX in research agreement with Shriners Hospitals

With the goal of identifying advanced treatment approaches for children with genetic orthopedic conditions, Shriners Hospitals for Children® and The Jackson Laboratory (JAX) have entered...

| By Kelley Gipson

Winstanley plans lab space project for New Haven

A prominent developer is proposing to build 500,000 square feet of laboratory and life-sciences incubation space in downtown New Haven. Winstanley Enterprises LLC plans a major...

| By Kelley Gipson

New Haven’s Wellinks to be acquired by Convexity

Wellinks, a six-year-old New Haven startup founded by Yale students who invented an internet-connected brace-monitoring strap for scoliosis patients, has been acquired by Fairfield respiratory...

| By Kelley Gipson

Alexion plans Phase 3 Study Of ULTOMIRIS® re ALS

Alexion Pharmaceuticals is planning to initiate a pivotal Phase 3 study of ULTOMIRIS® (ravulizumab) in amyotrophic lateral sclerosis (ALS). The 50-week global study, called CHAMPION-ALS,...

| By Kelley Gipson

Rothberg’s Hyperfine scores with portable MRI

Hyperfine Research is pioneering a portable, point-of-care MRI it plans to market later this year for around $50,000, a fraction of the price of conventional...

| By Kelley Gipson

UConn: Repeats influence genome biology

About 50% of human DNA today is made of duplicated sequences that are the remnants of transposition events that took place in our evolutionary history....

| By Kelley Gipson

Bayer and Azitra collaborate on skin bacteria

Bayer and Azitra have announced a joint development agreement to collaborate in the identification and characterization of skin microbiome bacteria. The partnership will leverage Azitra’s...

| By Kelley Gipson

SpringWorks collaborates with Allogene re myeloma

SpringWorks Therapeutics has entered into a clinical trial collaboration agreement with Allogene Therapeutics.. This agreement will evaluate ALLO-715, Allogene’s investigational anti-B-cell maturation antigen (BCMA) AlloCAR...